about
Viral oncolysates as human tumor vaccines.T cell responses to ovarian tumor vaccines: identification and significance for future immunotherapy.Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract.Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.
P2860
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh-hant
name
Immunotherapy with viral oncolysates for sarcoma.
@en
Immunotherapy with viral oncolysates for sarcoma.
@nl
type
label
Immunotherapy with viral oncolysates for sarcoma.
@en
Immunotherapy with viral oncolysates for sarcoma.
@nl
prefLabel
Immunotherapy with viral oncolysates for sarcoma.
@en
Immunotherapy with viral oncolysates for sarcoma.
@nl
P1476
Immunotherapy with viral oncolysates for sarcoma.
@en
P2093
J G Sinkovics
P356
10.1001/JAMA.1977.03270360031003
P407
P577
1977-02-01T00:00:00Z